Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.

Bong-Seog KimJong-Youl JinJung Hye KwonIn Sook WooYoon Ho KoSuk-Young ParkHye-Jeong ParkJin-Hyoung Kang

Published in: Asia-Pacific journal of clinical oncology (2017)

Oxycodone/naloxone added to pregabalin or gabapentin provided additional pain relief and symptom control in Korean patients with CIPN, without clinically significant safety concerns.

Keyphrases

neuropathic pain
chemotherapy induced
spinal cord
spinal cord injury
chronic pain
stem cells
patient reported
mesenchymal stem cells
postoperative pain
cell therapy